ConductScience.org, home

Comparison · NCT02759120-e2ec0ccd

Antimicrobial Therapy Plus Standard of Care vs Standard of Care: Number of Participants With First Non-elective, Respiratory Hospitalization

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Antimicrobial Therapy Plus Standard of Care vs Standard of Care: Number of Participants With First Non-elective, Respiratory Hospitalization. Trial comparisons, record NCT02759120-e2ec0ccd. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02759120-e2ec0ccd

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1420.1040.19wilson
Risk in group 20.120.08560.165wilson
Risk difference, group 1 minus group 20.022-0.03670.0811newcombe hybrid score
Risk ratio, group 1 over group 21.180.7571.85log
Odds ratio, group 1 over group 21.210.7262.03log
Number needed to treat, for one more participant with the outcome on Antimicrobial Therapy Plus Standard of Care than on Standard of Care45.4from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: standard of care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Antimicrobial Therapy Plus Standard of Care
Co-trimoxazole OR doxycycline~Antimicrobial therapy: Co-trimoxazole or Doxycycline: 160mg trimethoprim/800mg sulfamethoxazole (double strength co-trimoxazole) twice daily plus folic acid 5 mg daily OR doxycycline 100mg once daily if weight \< 50 kilograms or 100mg twice daily if weight \> 50 kilograms for up to 36 months
36254OG000
Group 2Standard of CareStandard of care for patients with IPF for comparison~No Intervention: Standard of Care: Standard of care31259OG001

Outcome

Type
SECONDARY
Title
Number of Participants With First Non-elective, Respiratory Hospitalization
Description
Time frame
Randomization to up to 35 months
Population

Source ClinicalTrials.gov

Trial

Title
CleanUP IPF for the Pulmonary Trials Cooperative
NCT number
NCT02759120
Phases
PHASE3
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
Antimicrobial therapy: Co-trimoxazole or Doxycycline, No Intervention: Standard of Care
Lead sponsor
Weill Medical College of Cornell University
Results first posted
2021-03-03

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02759120-e2ec0ccd